Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep

Hypertension

Volumn 65, Issue 2, 2015, Pages 393-400

  Booth, Lindsea C ^a   Nishi, Erika E ^c   Yao, Song T ^a   Ramchandra, Rohit ^a   Lambert, Gavin W ^b   Schlaich, Markus P ^b   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cardiovascular diseases; catheter ablation; electric stimulation

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; CAPSAICIN;

ABLATION CATHETER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETER; CATHETER ABLATION; CHRONOSEQUENCE; CONTROLLED STUDY; EFFERENT NERVE; ELECTROSTIMULATION; FUNCTIONAL ANATOMY; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY DENERVATION; KIDNEY INNERVATION; KIDNEY NERVE; MEAN ARTERIAL PRESSURE; NERVE STIMULATION; NONHUMAN; OVINE MODEL; PRIORITY JOURNAL; REINNERVATION; SENSORY NERVE; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE; SYMPLICITY FLEX CATHETER; ANIMAL; BLOOD PRESSURE; CHEMISTRY; ENZYMOLOGY; FEMALE; HEMODYNAMICS; HYPERTENSION; INNERVATION; KIDNEY; NERVE FIBER TRANSECTION; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE PERIOD; PROCEDURES; SENSORY NERVE CELL; SHEEP; SPLANCHNIC NERVE; SYMPATHECTOMY; TIME;

AFFERENT PATHWAYS; ANIMALS; AXOTOMY; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CATHETER ABLATION; EFFERENT PATHWAYS; ELECTRIC STIMULATION; FEMALE; HEMODYNAMICS; HYPERTENSION; KIDNEY; NERVE REGENERATION; NEURONS, AFFERENT; NEURONS, EFFERENT; NOREPINEPHRINE; POSTOPERATIVE PERIOD; SHEEP; SPLANCHNIC NERVES; SYMPATHECTOMY; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 84921598910     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04176     Document Type: Article

References (30)

1. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75-197.
2. Katholi RE. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol. 1983;245:F1-14.
3. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A. 1989;11(suppl 1):75-89.
4. Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet. 1953;1:403-408.
5. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheterbased renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
6. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126:2976-2982.
7. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383:622-629.
8. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-1401.
9. Katholi RE, Woods WT. Afferent renal nerves and hypertension. Clin Exp Hypertens A. 1987;9(suppl 1):211-226.
10. Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis. 1995;26:861-865.
11. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-934.
12. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457-464.
13. Ezzahti M, Moelker A, Friesema EC, van der Linde NA, Krestin GP, van den Meiracker AH. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension. J Hypertens. 2014;32:135-141.
14. Mulder J, Hökfelt T, Knuepfer MM, Kopp UC. Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats. Am J Physiol Regul Integr Comp Physiol. 2013;304:R675-R682.
15. Kline RL, Mercer PF. Functional reinnervation and development of supersensitivity to NE after renal denervation in rats. Am J Physiol. 1980;238:R353-R358.
16. Gazdar AF, Dammin GJ. Neural degeneration and regeneration in human renal transplants. N Engl J Med. 1970;283:222-224.
17. Norvell JE, Weitsen HA, Sheppek CG. The intrinsic innervation of human renal homotransplants. Transplantation. 1970;9:168-176.
18. Cohen-Mazor M, Mathur P, Stanley JR, Mendelsohn FO, Lee H, Baird R, Zani BG, Markham PM, Rocha-Singh K. Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model. J Hypertens. 2014;32:1678-1691, discussion 1691.
19. Henegar JR, Zhang Y, Rama RD, Hata C, Hall ME, Hall JE. Catheterbased radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. Am J Hypertens. 2014;27:1285-1292.
20. May CN, McAllen RM. Brain angiotensinergic pathways mediate renal nerve inhibition by central hypertonic NaCl in conscious sheep. Am J Physiol. 1997;272(2 Pt 2):R593-R600.
21. Stani D, Kuteeva E, Nylander I, Hökfelt T. Characterization of CGRP protein expression in "satellite-like" cells and dendritic arbours of the mouse olfactory bulb. J Comp Neurol. 2010;518:770-784.
22. Lambert GW, Jonsdottir IH. Influence of voluntary exercise on hypothalamic norepinephrine. J Appl Physiol (1985). 1998;85:962-966.
23. Fox J. The r commander: A basic statistics graphical user interface to r. J Stat Softw. 2005;14:1-42.
24. R Core Team. R: A language and environment for statistical computing. 2013.
25. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300:230-235.
26. Booth LC, Bennet L, Guild SJ, Barrett CJ, May CN, Gunn AJ, Malpas SC. Maturation-related changes in the pattern of renal sympathetic nerve activity from fetal life to adulthood. Exp Physiol. 2011;96:85-93.
27. Ramchandra R, Hood SG, Frithiof R, May CN. Discharge properties of cardiac and renal sympathetic nerves and their impaired responses to changes in blood volume in heart failure. Am J Physiol Regul Integr Comp Physiol. 2009;297:R665-R674.
28. Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol. 1994;4:1901-1907.
29. Vink EE, Goldschmeding R, Vink A, Weggemans C, Bleijs RL, Blankestijn PJ. Limited destruction of renal nerves after catheter-based renal denervation: results of a human case study. Nephrol Dial Transplant. 2014;29:1608-1610.
30. Xing J, Lu J, Li J. Nerve growth factor decreases in sympathetic and sensory nerves of rats with chronic heart failure. Neurochem Res. 2014;39:1564-1570.